Wave Life Sciences Ltd. 8-K Filing
Ticker: WVE · Form: 8-K · Filed: Dec 8, 2025 · CIK: 1631574
| Field | Detail |
|---|---|
| Company | Wave Life Sciences Ltd. (WVE) |
| Form Type | 8-K |
| Filed Date | Dec 8, 2025 |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Wave Life Sciences Ltd. (ticker: WVE) to the SEC on Dec 8, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0 (e of each exchange on which registered $0 Par Value Ordinary Shares WVE The N).
How long is this filing?
Wave Life Sciences Ltd.'s 8-K filing is 2 pages with approximately 668 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 668 words · 3 min read · ~2 pages · Grade level 10.2 · Accepted 2025-12-08 07:37:55
Key Financial Figures
- $0 — e of each exchange on which registered $0 Par Value Ordinary Shares WVE The N
Filing Documents
- d20484d8k.htm (8-K) — 26KB
- d20484dex991.htm (EX-99.1) — 25KB
- g20484dsp01.jpg (GRAPHIC) — 7KB
- g20484g1208064526447.jpg (GRAPHIC) — 66KB
- 0001193125-25-310595.txt ( ) — 273KB
- wve-20251208.xsd (EX-101.SCH) — 3KB
- wve-20251208_lab.xml (EX-101.LAB) — 18KB
- wve-20251208_pre.xml (EX-101.PRE) — 11KB
- d20484d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d)Exhibits The following exhibit relating to Item 7.01 is furnished and not filed: Exhibit No. Description 99.1 Press Release issued by Wave Life Sciences Ltd. dated December 8, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WAVE LIFE SCIENCES LTD. By: /s/ Paul B. Bolno, M.D Paul B. Bolno, M.D. President and Chief Executive Officer Date: December 8, 2025